Phibro Animal Health Corp

CEO Jack Bendheim Trims 20% of Phibro Animal Health Stock in Structured Plan, Signals Strategic Shift to Board‑Level Role

Phibro CEO Jack Bendheim’s 10b5‑1 trades signal a gradual stake‑reduction while keeping voting power—insider moves that hint at future leadership and growth plans.

Phibro Animal Health Corp
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

06/02/2026, 02:21

3 minutes to read

CEO Jack Bendheim Sells Nearly 7,000 Shares at $41.25 Each, Raising Questions Over Phibro’s Short‑Term Outlook

Phibro Animal Health CEO Jack Bendheim’s recent 10b‑5‑1 stock sales signal cautious liquidity use amid solid earnings and future growth prospects.

Phibro Animal Health Corp
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

06/02/2026, 01:38

3 minutes to read